US Stock MarketDetailed Quotes

Nuvectis Pharma (NVCT)

Watchlist
  • 12.450
  • +0.410+3.41%
Close May 14 16:00 ET
  • 11.740
  • -0.710-5.70%
Post 17:55 ET
330.24MMarket Cap-9.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nuvectis Pharma (NVCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-55.99%-6.51M
-30.72%-16.01M
-61.22%-3.97M
-86.94%-4.49M
-11.49%-3.37M
4.22%-4.17M
23.24%-12.25M
35.97%-2.47M
25.89%-2.4M
26.03%-3.02M
Net income from continuing operations
-13.47%-6.05M
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
Change In working capital
-1,000.48%-2.31M
132.24%4.4M
-29.45%1.86M
156.10%1.51M
746.58%1.24M
85.84%-210K
18.36%1.9M
70.23%2.64M
-60.77%590K
-78.37%146K
-Change in payables and accrued expense
---2.12M
1,907.24%3.05M
-114.47%-115K
294.06%1.53M
526.34%1.64M
--0
-87.82%152K
-43.54%795K
-71.67%387K
-5.07%262K
-Change in other current assets
8.10%-193K
93.33%-1K
9.38%70K
56.82%69K
2.94%70K
-9.95%-210K
-104.25%-15K
-55.56%64K
-68.12%44K
-82.96%68K
-Change in other working capital
----
-23.15%1.35M
7.07%1.91M
-152.20%-83K
----
----
--1.76M
--1.78M
--159K
----
Cash from discontinued investing activities
Operating cash flow
-55.99%-6.51M
-30.72%-16.01M
-61.22%-3.97M
-86.94%-4.49M
-11.49%-3.37M
4.22%-4.17M
23.24%-12.25M
35.97%-2.47M
25.89%-2.4M
26.03%-3.02M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-99.95%7K
149.79%29.11M
-95.66%166K
802.06%13.14M
-82.30%296K
230.17%15.51M
-22.75%11.65M
317.56%3.83M
107.25%1.46M
-87.35%1.67M
Net common stock issuance
-99.96%7K
159.31%31.21M
-93.73%248K
799.14%13.55M
-64.45%614K
246.42%16.8M
127.57%12.04M
338.73%3.95M
33.84%1.51M
-47.06%1.73M
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
--0
--0
--0
Net other financing activities
----
-449.74%-2.1M
33.87%-82K
-714.00%-407K
-478.18%-318K
-745.10%-1.29M
72.60%-382K
-875.00%-124K
88.56%-50K
89.48%-55K
Cash from discontinued financing activities
Financing cash flow
-99.95%7K
149.79%29.11M
-95.66%166K
802.06%13.14M
-82.30%296K
230.17%15.51M
-22.75%11.65M
317.56%3.83M
107.25%1.46M
-87.35%1.67M
Net cash flow
Beginning cash position
70.69%31.63M
-3.10%18.53M
106.43%35.44M
47.90%26.79M
53.43%29.86M
-3.10%18.53M
-4.34%19.13M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
Current changes in cash
-157.40%-6.5M
2,309.27%13.1M
-379.18%-3.81M
1,013.31%8.65M
-127.82%-3.07M
3,252.37%11.33M
31.60%-593K
146.51%1.36M
62.73%-947K
-114.76%-1.35M
End cash Position
-15.85%25.13M
70.69%31.63M
70.69%31.63M
106.43%35.44M
47.90%26.79M
53.43%29.86M
-3.10%18.53M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
Free cash flow
-55.99%-6.51M
-30.72%-16.01M
-61.22%-3.97M
-86.94%-4.49M
-11.49%-3.37M
4.22%-4.17M
23.24%-12.25M
35.97%-2.47M
25.89%-2.4M
26.03%-3.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -55.99%-6.51M-30.72%-16.01M-61.22%-3.97M-86.94%-4.49M-11.49%-3.37M4.22%-4.17M23.24%-12.25M35.97%-2.47M25.89%-2.4M26.03%-3.02M
Net income from continuing operations -13.47%-6.05M-39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M
Change In working capital -1,000.48%-2.31M132.24%4.4M-29.45%1.86M156.10%1.51M746.58%1.24M85.84%-210K18.36%1.9M70.23%2.64M-60.77%590K-78.37%146K
-Change in payables and accrued expense ---2.12M1,907.24%3.05M-114.47%-115K294.06%1.53M526.34%1.64M--0-87.82%152K-43.54%795K-71.67%387K-5.07%262K
-Change in other current assets 8.10%-193K93.33%-1K9.38%70K56.82%69K2.94%70K-9.95%-210K-104.25%-15K-55.56%64K-68.12%44K-82.96%68K
-Change in other working capital -----23.15%1.35M7.07%1.91M-152.20%-83K----------1.76M--1.78M--159K----
Cash from discontinued investing activities
Operating cash flow -55.99%-6.51M-30.72%-16.01M-61.22%-3.97M-86.94%-4.49M-11.49%-3.37M4.22%-4.17M23.24%-12.25M35.97%-2.47M25.89%-2.4M26.03%-3.02M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -99.95%7K149.79%29.11M-95.66%166K802.06%13.14M-82.30%296K230.17%15.51M-22.75%11.65M317.56%3.83M107.25%1.46M-87.35%1.67M
Net common stock issuance -99.96%7K159.31%31.21M-93.73%248K799.14%13.55M-64.45%614K246.42%16.8M127.57%12.04M338.73%3.95M33.84%1.51M-47.06%1.73M
Proceeds from stock option exercised by employees --------------------------0--0--0--0
Net other financing activities -----449.74%-2.1M33.87%-82K-714.00%-407K-478.18%-318K-745.10%-1.29M72.60%-382K-875.00%-124K88.56%-50K89.48%-55K
Cash from discontinued financing activities
Financing cash flow -99.95%7K149.79%29.11M-95.66%166K802.06%13.14M-82.30%296K230.17%15.51M-22.75%11.65M317.56%3.83M107.25%1.46M-87.35%1.67M
Net cash flow
Beginning cash position 70.69%31.63M-3.10%18.53M106.43%35.44M47.90%26.79M53.43%29.86M-3.10%18.53M-4.34%19.13M-22.17%17.17M-26.36%18.12M25.83%19.46M
Current changes in cash -157.40%-6.5M2,309.27%13.1M-379.18%-3.81M1,013.31%8.65M-127.82%-3.07M3,252.37%11.33M31.60%-593K146.51%1.36M62.73%-947K-114.76%-1.35M
End cash Position -15.85%25.13M70.69%31.63M70.69%31.63M106.43%35.44M47.90%26.79M53.43%29.86M-3.10%18.53M-3.10%18.53M-22.17%17.17M-26.36%18.12M
Free cash flow -55.99%-6.51M-30.72%-16.01M-61.22%-3.97M-86.94%-4.49M-11.49%-3.37M4.22%-4.17M23.24%-12.25M35.97%-2.47M25.89%-2.4M26.03%-3.02M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -